Breaking News Instant updates and real-time market news.

AET

Aetna

$195.25

0.03 (0.02%)

06:31
10/30/18
10/30
06:31
10/30/18
06:31

Aetna reports Q3 GAAP revenue $15.48B, consensus $15.29B

AET Aetna
$195.25

0.03 (0.02%)

10/22/18
FBCO
10/22/18
NO CHANGE
Target $207
FBCO
Neutral
Aetna price target raised to $207 from $202 at Credit Suisse
Credit Suisse analyst A.J. Rice raised his price target for Aetna (AET) to $207 from $202, while reiterating a Neutral rating on the shares. The analyst noted that the DOJ preliminary approved CVS' (CVS) acquisition of Aetna after the latter reached an agreement to sell its Medicare Part D drug plan business to WellCare Health Plans. Connecticut approved the CVS-AET deal October 17, and New York is expected to reach a decision after October 25, Rice adds. At this point, the analyst feels deal approval has a high probability of occurring, albeit the timing could be slightly later than CVS' outlook of early Q4 closing. Overall, Rice is putting a 90%-95% probability on the deal closure.
10/02/18
LEER
10/02/18
NO CHANGE
LEER
Outperform
Intersect ENT's Sinuva reimbursement policies 'steps in right direction,' says Leerink
Leerink analyst Richard Newitter reiterates an Outperform rating on Intersect ENT following some positive progress on the reimbursement front for Sinuva in the last several weeks, namely Aetna (AET) covering Sinuva and Anthem (ATNM) adding it to its formulary this past week. The analyst believes these positive coverage policies represent steps in the right direction to a potentially quicker and more consistent reimbursement process using the specialty pharmacy channel, an area where the company has faced some challenges.
09/17/18
RBCM
09/17/18
NO CHANGE
Target $101
RBCM
Outperform
CVS Health price target raised to $101 from $90 at RBC Capital
RBC Capital analyst George Hill raised his price target on CVS Health (CVS) to $101 and kept his Outperform rating, citing the increased visibility of the company's merger with Aetna (AET) after its recent comments that it expects the deal to close in early Q4. The analyst also points to "de-risked" CVS investment thesis as it pertains to pharmacy benefit managers rebates and the much higher relative multiples for managed care companies, even though he warns that investors may still be spooked by any potential steps that the White House takes to drive prescription drug prices lower. Hill notes however that the latest government funding bill pulled the text that required drug companies to disclose prices in their ads, implying that the political will to change status quo may be limited.
09/10/18
SDLR
09/10/18
INITIATION
Target $60
SDLR
Buy
Hartford Financial initiated with a Buy at Sandler ONeill
Sandler ONeill analyst Paul Newsome initiated Hartford Financial (HIG) with a Buy rating and $60 price target, citing his view that its valuation is "relatively attractive" and that the biggest near-term risk for investors has been resolved by the purchase of The Navigators Group (NAVG), which he sees having several benefits. Newsome also believes the recent acquisition of Aetna's (AET) benefits business will be a relatively strong earnings growth opportunity, he tells investors.

TODAY'S FREE FLY STORIES

CTWS

Connecticut Water

$69.51

-0.24 (-0.34%)

09:30
11/19/18
11/19
09:30
11/19/18
09:30
Hot Stocks
Connecticut Water announces $85.7M capital spending plan for 2019 »

Connecticut Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXFO

EXFO Inc.

$3.63

0.04 (1.11%)

09:30
11/19/18
11/19
09:30
11/19/18
09:30
Hot Stocks
EXFO Inc. CEO, Chairman purchase shares of company stock »

EXFO Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OVID

Ovid Therapeutics

$4.63

0.14 (3.12%)

09:27
11/19/18
11/19
09:27
11/19/18
09:27
Conference/Events
Ovid Therapeutics management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 27

    Nov

TRGP

Targa Resources

$47.44

0.25 (0.53%)

09:26
11/19/18
11/19
09:26
11/19/18
09:26
Upgrade
Targa Resources rating change  »

Targa Resources upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$129.96

0.52 (0.40%)

09:26
11/19/18
11/19
09:26
11/19/18
09:26
Periodicals
Barloworld in talks to purchase a Caterpillar business, Reuters reports »

Barloworld is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

PCG

PG&E

$24.39

6.62 (37.25%)

09:25
11/19/18
11/19
09:25
11/19/18
09:25
Recommendations
PG&E analyst commentary  »

PG&E break-up could…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPAY

Bottomline Technologies

$56.47

0.35 (0.62%)

, GDOT

Green Dot

$84.81

1.88 (2.27%)

09:25
11/19/18
11/19
09:25
11/19/18
09:25
Conference/Events
Citigroup financial analysts to hold an analyst/industry conference call »

Financial Analysts review…

EPAY

Bottomline Technologies

$56.47

0.35 (0.62%)

GDOT

Green Dot

$84.81

1.88 (2.27%)

MA

MasterCard

$199.11

-1.7 (-0.85%)

PYPL

PayPal

$85.04

-1.71 (-1.97%)

SQ

Square

$70.55

-3.045 (-4.14%)

V

Visa

$140.25

-1.655 (-1.17%)

WP

Worldpay

$82.05

-0.62 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 12

    Dec

  • 12

    Dec

  • 18

    Dec

  • 18

    Dec

  • 29

    Jan

09:25
11/19/18
11/19
09:25
11/19/18
09:25
General news
Breaking General news story  »

New York Federal Reserve…

BYSI

BeyondSpring

$21.42

(0.00%)

09:24
11/19/18
11/19
09:24
11/19/18
09:24
Conference/Events
BeyondSpring management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

EMN

Eastman Chemical

$83.11

0.34 (0.41%)

09:22
11/19/18
11/19
09:22
11/19/18
09:22
Recommendations
Eastman Chemical analyst commentary  »

Eastman Chemical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YETI

Yeti

$16.99

0.1 (0.59%)

09:21
11/19/18
11/19
09:21
11/19/18
09:21
Initiation
Yeti initiated  »

William Blair starts Yeti…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

09:20
11/19/18
11/19
09:20
11/19/18
09:20
General news
U.S. NAHB housing market index preview: »

U.S. NAHB housing market…

ADS

Alliance Data

$198.00

0.38 (0.19%)

09:18
11/19/18
11/19
09:18
11/19/18
09:18
Recommendations
Alliance Data analyst commentary  »

Alliance Data price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORT

Corcept Therapeutics

$13.02

0.005 (0.04%)

09:18
11/19/18
11/19
09:18
11/19/18
09:18
Hot Stocks
Corcept Therapeutics doses first patient in Phase 3 trial of relacorilant »

Corcept Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

09:18
11/19/18
11/19
09:18
11/19/18
09:18
Options
Overnight activity included 313 trades in SPX and 10 trades in VIX »

313 trades were executed…

SPX

S&P 500

$0.00

(0.00%)

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLTZY

Tele2

$0.00

(0.00%)

09:17
11/19/18
11/19
09:17
11/19/18
09:17
Upgrade
Tele2 rating change  »

Tele2 upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$1.23

-0.365 (-22.88%)

09:16
11/19/18
11/19
09:16
11/19/18
09:16
Hot Stocks
Akers Biosciences considering business combinations in cannabis related industry »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APDN

Applied DNA Sciences

$1.08

-0.015 (-1.37%)

09:15
11/19/18
11/19
09:15
11/19/18
09:15
Hot Stocks
Applied DNA Sciences, Eurofins sign collaboration agreement »

Applied DNA Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REN

Resolute Energy

$30.51

0.67 (2.25%)

, VKTX

Viking Therapeutics

$11.65

0.27 (2.37%)

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Resolute Energy…

REN

Resolute Energy

$30.51

0.67 (2.25%)

VKTX

Viking Therapeutics

$11.65

0.27 (2.37%)

ZAYO

Zayo Group

$23.70

1.495 (6.73%)

LEJU

Leju

$1.71

0.05 (3.01%)

JD

JD.com

$23.04

-1.18 (-4.87%)

XEC

Cimarex Energy

$88.63

-0.27 (-0.30%)

PCG

PG&E

$24.39

6.62 (37.25%)

MDGL

Madrigal Pharmaceuticals

$129.47

-3.36 (-2.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 03

    Dec

IRT

Independence Realty Trust

$9.99

0.21 (2.15%)

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Initiation
Independence Realty Trust initiated  »

Independence Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACC

American Campus

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Initiation
American Campus initiated  »

American Campus initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDR

UDR, Inc.

$41.06

0.6 (1.48%)

09:14
11/19/18
11/19
09:14
11/19/18
09:14
Initiation
UDR, Inc. initiated  »

UDR, Inc. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMRN

Immuron

$8.50

(0.00%)

, SGYP

Synergy Pharmaceuticals

$0.39

0.0211 (5.73%)

09:13
11/19/18
11/19
09:13
11/19/18
09:13
Hot Stocks
Immuron appoints Gary Jacob CEO »

Immuron (IMRN) announced…

IMRN

Immuron

$8.50

(0.00%)

SGYP

Synergy Pharmaceuticals

$0.39

0.0211 (5.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

INTC

Intel

$48.85

0.73 (1.52%)

09:12
11/19/18
11/19
09:12
11/19/18
09:12
Recommendations
Intel analyst commentary  »

Intel to benefit from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

OTEX

OpenText

$33.20

0.32 (0.97%)

09:10
11/19/18
11/19
09:10
11/19/18
09:10
Hot Stocks
Sun Chemical selects OpenText to improve customer service »

OpenText announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.